Literature DB >> 22914363

Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland.

Alex-Mikael Barkoff, Jussi Mertsola, Sophie Guillot, Nicole Guiso, Guy Berbers, Qiushui He.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22914363      PMCID： PMC3485885          DOI： 10.1128/CVI.00367-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


× No keyword cloud information.
  9 in total

1.  Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants?

Authors:  Qiushui He; Johanna Mäkinen; Guy Berbers; Frits R Mooi; Matti K Viljanen; Heikki Arvilommi; Jussi Mertsola
Journal:  J Infect Dis       Date:  2003-03-26       Impact factor: 5.226

2.  First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.

Authors:  V Bouchez; D Brun; T Cantinelli; G Dore; E Njamkepo; N Guiso
Journal:  Vaccine       Date:  2009-08-08       Impact factor: 3.641

Review 3.  Rationale for pertussis booster vaccination throughout life in Europe.

Authors:  Fred Zepp; Ulrich Heininger; Jussi Mertsola; Ewa Bernatowska; Nicole Guiso; John Roord; Alberto E Tozzi; Pierre Van Damme
Journal:  Lancet Infect Dis       Date:  2011-05-18       Impact factor: 25.071

Review 4.  Bordetella pertussis and pertussis vaccines.

Authors:  Nicole Guiso
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

5.  A natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cells.

Authors:  Paola Stefanelli; Cecilia Fazio; Giorgio Fedele; Fabiana Spensieri; Clara Maria Ausiello; Paola Mastrantonio
Journal:  New Microbiol       Date:  2009-04       Impact factor: 2.479

Review 6.  Bordetella pertussis strain variation and evolution postvaccination.

Authors:  Teemu Kallonen; Qiushui He
Journal:  Expert Rev Vaccines       Date:  2009-07       Impact factor: 5.217

7.  Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.

Authors:  Nao Otsuka; Hyun-Ja Han; Hiromi Toyoizumi-Ajisaka; Yukitsugu Nakamura; Yoshichika Arakawa; Keigo Shibayama; Kazunari Kamachi
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

8.  Rapid identification of Bordetella pertussis pertactin gene variants using LightCycler real-time polymerase chain reaction combined with melting curve analysis and gel electrophoresis.

Authors:  J Mäkinen; M K Viljanen; J Mertsola; H Arvilommi; Q He
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

9.  Bordetella pertussis isolates in Finland: serotype and fimbrial expression.

Authors:  Eriikka Heikkinen; Dorothy K Xing; Rose-Marie Olander; Jukka Hytönen; Matti K Viljanen; Jussi Mertsola; Qiushui He
Journal:  BMC Microbiol       Date:  2008-09-25       Impact factor: 3.605
  9 in total
  36 in total

Review 1.  Bordetella pertussis evolution in the (functional) genomics era.

Authors:  Thomas Belcher; Andrew Preston
Journal:  Pathog Dis       Date:  2015-08-21       Impact factor: 3.166

Review 2.  Prevention of pertussis: An unresolved problem.

Authors:  Susanna Esposito; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2018-07-24       Impact factor: 3.452

3.  How to fight pertussis?

Authors:  Nicole Guiso
Journal:  Ther Adv Vaccines       Date:  2013-07

4.  Bordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cells.

Authors:  Jolanda Brummelman; Rosanne E Veerman; Hendrik Jan Hamstra; Anna J M Deuss; Tim J Schuijt; Arjen Sloots; Betsy Kuipers; Cécile A C M van Els; Peter van der Ley; Frits R Mooi; Wanda G H Han; Elena Pinelli
Journal:  Infect Immun       Date:  2014-10-27       Impact factor: 3.441

5.  The History of Bordetella pertussis Genome Evolution Includes Structural Rearrangement.

Authors:  Michael R Weigand; Yanhui Peng; Vladimir Loparev; Dhwani Batra; Katherine E Bowden; Mark Burroughs; Pamela K Cassiday; Jamie K Davis; Taccara Johnson; Phalasy Juieng; Kristen Knipe; Marsenia H Mathis; Andrea M Pruitt; Lori Rowe; Mili Sheth; M Lucia Tondella; Margaret M Williams
Journal:  J Bacteriol       Date:  2017-03-28       Impact factor: 3.490

6.  Strain variation and antigenic divergence among Bordetella pertussis circulating strains isolated from patients in Iran.

Authors:  Fatemah Sadeghpour Heravi; Vajihe Sadat Nikbin; Masomeh Nakhost Lotfi; Pouran Badiri; Nazanin Jannesar Ahmadi; Seyed Mohsen Zahraei; Fereshteh Shahcheraghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-09       Impact factor: 3.267

7.  Pertactin-negative variants of Bordetella pertussis in the United States.

Authors:  Anne Marie Queenan; Pamela K Cassiday; Alan Evangelista
Journal:  N Engl J Med       Date:  2013-02-07       Impact factor: 91.245

8.  Molecular epidemiology of the pertussis epidemic in Washington State in 2012.

Authors:  Katherine E Bowden; Margaret M Williams; Pamela K Cassiday; Andrea Milton; Lucia Pawloski; Marsenia Harrison; Stacey W Martin; Sarah Meyer; Xuan Qin; Chas DeBolt; Azadeh Tasslimi; Nusrat Syed; Ronald Sorrell; Mike Tran; Brian Hiatt; Maria Lucia Tondella
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

Review 9.  Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.

Authors:  Dorji Dorji; Frits Mooi; Osvaldo Yantorno; Rajendar Deora; Ross M Graham; Trilochan K Mukkur
Journal:  Med Microbiol Immunol       Date:  2017-11-21       Impact factor: 3.402

Review 10.  Novel therapies for the treatment of pertussis disease.

Authors:  Karen M Scanlon; Ciaran Skerry; Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2015-09-21       Impact factor: 3.166
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.